P-159 First-in-human phase 1 dose-escalating study protocol of pressurized intraperitoneal aerosol chemotherapy with paclitaxel in peritoneal carcinomatosis (PIPAC2 study)
Kim G, Tan H, Sundar R, Wang L, Shabbir A, Yong W, So J. P-159 First-in-human phase 1 dose-escalating study protocol of pressurized intraperitoneal aerosol chemotherapy with paclitaxel in peritoneal carcinomatosis (PIPAC2 study). Annals Of Oncology 2020, 31: s141. DOI: 10.1016/j.annonc.2020.04.241.Peer-Reviewed Original Research